Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1990 Jun;85(6):1740–1745. doi: 10.1172/JCI114630

v-rasH induces non-small cell phenotype, with associated growth factors and receptors, in a small cell lung cancer cell line.

J P Falco 1, S B Baylin 1, R Lupu 1, M Borges 1, B D Nelkin 1, R K Jasti 1, N E Davidson 1, M Mabry 1
PMCID: PMC296635  PMID: 2161428

Abstract

Small cell lung cancer (SCLC) tumor progression can involve partial or complete conversion to a more treatment-resistant non-small cell (NSCLC) phenotype. In a cell culture model of this phenomenon, we have previously demonstrated that insertion of the viral Harvey ras gene (v-Ha-ras) into SCLC cell lines with amplification and overexpression of the c-myc gene induced many NSCLC phenotypic features. We now report that the v-Ha-ras gene can also induce morphologic, biochemical, and growth characteristics consistent with the NSCLC phenotype in an N-myc amplified SCLC cell line, NCI-H249. We show that v-Ha-ras has novel effects on these cells, abrogating an SCLC-specific growth requirement for gastrin-releasing peptide, and inducing mRNA expression of three NSCLC-associated growth factors and receptors, platelet-derived growth factor B chain, transforming growth factor-alpha (TGF-alpha), and epidermal growth factor receptor (EGF-R). TGF-alpha secretion and EGF-R also appear, consistent with the induction of an autocrine loop previously shown to be growth stimulatory for NSCLC in culture. These data suggest that N-myc and v-Ha-ras represent functional classes of genes that may complement each other in bringing about the phenotypic alterations seen during SCLC tumor progression, and suggest that such alterations might include the appearance of growth factors and receptors of potential importance for the growth of the tumor and its surrounding stroma.

Full text

PDF
1740

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abeloff M. D., Eggleston J. C., Mendelsohn G., Ettinger D. S., Baylin S. B. Changes in morphologic and biochemical characteristics of small cell carcinoma of the lung. A clinicopathologic study. Am J Med. 1979 May;66(5):757–764. doi: 10.1016/0002-9343(79)91113-6. [DOI] [PubMed] [Google Scholar]
  2. Bates S. E., Davidson N. E., Valverius E. M., Freter C. E., Dickson R. B., Tam J. P., Kudlow J. E., Lippman M. E., Salomon D. S. Expression of transforming growth factor alpha and its messenger ribonucleic acid in human breast cancer: its regulation by estrogen and its possible functional significance. Mol Endocrinol. 1988 Jun;2(6):543–555. doi: 10.1210/mend-2-6-543. [DOI] [PubMed] [Google Scholar]
  3. Baylin S. B., Mendelsohn G. Ectopic (inappropriate) hormone production by tumors: mechanisms involved and the biological and clinical implications. Endocr Rev. 1980 Winter;1(1):45–77. doi: 10.1210/edrv-1-1-45. [DOI] [PubMed] [Google Scholar]
  4. Baylin S. B., Weisburger W. R., Eggleston J. C., Mendelsohn G., Beaven M. A., Abeloff M. D., Ettinger D. S. Variable content of histaminase, L-dopa decarboxylase and calcitonin in small-cell carcinoma of the lung. Biologic and clinical implications. N Engl J Med. 1978 Jul 20;299(3):105–110. doi: 10.1056/NEJM197807202990301. [DOI] [PubMed] [Google Scholar]
  5. Bepler G., Carney D. N., Nau M. M., Gazdar A. F., Minna J. D. Additive and differential biological activity of alpha-interferon A, difluoromethylornithine, and their combination on established human lung cancer cell lines. Cancer Res. 1986 Jul;46(7):3413–3419. [PubMed] [Google Scholar]
  6. Berger C. L., Goodwin G., Mendelsohn G., Eggleston J. C., Abeloff M. D., Aisner S., Baylin S. B. Endocrine-related biochemistry in the spectrum of human lung carcinoma. J Clin Endocrinol Metab. 1981 Aug;53(2):422–429. doi: 10.1210/jcem-53-2-422. [DOI] [PubMed] [Google Scholar]
  7. Bergh J., Nilsson K., Zech L., Giovanella B. Establishment and characterization of a continuous lung squamous cell carcinoma cell line (U-1752). Anticancer Res. 1981;1(6):317–322. [PubMed] [Google Scholar]
  8. Bergh J. The expression of the platelet-derived and transforming growth factor genes in human nonsmall lung cancer cell lines is related to tumor stroma formation in nude mice tumors. Am J Pathol. 1988 Dec;133(3):434–439. [PMC free article] [PubMed] [Google Scholar]
  9. Brereton H. D., Mathews M. M., Costa J., Kent C. H., Johnson R. E. Mixed anaplastic small-cell and squamous-cell carcinoma of the lung. Ann Intern Med. 1978 Jun;88(6):805–806. doi: 10.7326/0003-4819-88-6-805. [DOI] [PubMed] [Google Scholar]
  10. Carney D. N., Bunn P. A., Jr, Gazdar A. F., Pagan J. A., Minna J. D. Selective growth in serum-free hormone-supplemented medium of tumor cells obtained by biopsy from patients with small cell carcinoma of the lung. Proc Natl Acad Sci U S A. 1981 May;78(5):3185–3189. doi: 10.1073/pnas.78.5.3185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Carney D. N., Cuttitta F., Moody T. W., Minna J. D. Selective stimulation of small cell lung cancer clonal growth by bombesin and gastrin-releasing peptide. Cancer Res. 1987 Feb 1;47(3):821–825. [PubMed] [Google Scholar]
  12. Carney D. N., Gazdar A. F., Bepler G., Guccion J. G., Marangos P. J., Moody T. W., Zweig M. H., Minna J. D. Establishment and identification of small cell lung cancer cell lines having classic and variant features. Cancer Res. 1985 Jun;45(6):2913–2923. [PubMed] [Google Scholar]
  13. Cerny T., Barnes D. M., Hasleton P., Barber P. V., Healy K., Gullick W., Thatcher N. Expression of epidermal growth factor receptor (EGF-R) in human lung tumours. Br J Cancer. 1986 Aug;54(2):265–269. doi: 10.1038/bjc.1986.172. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Cuttitta F., Fedorko J., Gu J. A., Lebacq-Verheyden A. M., Linnoila R. I., Battey J. F. Gastrin-releasing peptide gene-associated peptides are expressed in normal human fetal lung and small cell lung cancer: a novel peptide family found in man. J Clin Endocrinol Metab. 1988 Sep;67(3):576–583. doi: 10.1210/jcem-67-3-576. [DOI] [PubMed] [Google Scholar]
  15. Devare S. G., Reddy E. P., Law J. D., Robbins K. C., Aaronson S. A. Nucleotide sequence of the simian sarcoma virus genome: demonstration that its acquired cellular sequences encode the transforming gene product p28sis. Proc Natl Acad Sci U S A. 1983 Feb;80(3):731–735. doi: 10.1073/pnas.80.3.731. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Dickson R. B., Bates S. E., McManaway M. E., Lippman M. E. Characterization of estrogen responsive transforming activity in human breast cancer cell lines. Cancer Res. 1986 Apr;46(4 Pt 1):1707–1713. [PubMed] [Google Scholar]
  17. Doolittle R. F., Hunkapiller M. W., Hood L. E., Devare S. G., Robbins K. C., Aaronson S. A., Antoniades H. N. Simian sarcoma virus onc gene, v-sis, is derived from the gene (or genes) encoding a platelet-derived growth factor. Science. 1983 Jul 15;221(4607):275–277. doi: 10.1126/science.6304883. [DOI] [PubMed] [Google Scholar]
  18. Eva A., Robbins K. C., Andersen P. R., Srinivasan A., Tronick S. R., Reddy E. P., Ellmore N. W., Galen A. T., Lautenberger J. A., Papas T. S. Cellular genes analogous to retroviral onc genes are transcribed in human tumour cells. Nature. 1982 Jan 14;295(5845):116–119. doi: 10.1038/295116a0. [DOI] [PubMed] [Google Scholar]
  19. Feinberg A. P., Vogelstein B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem. 1983 Jul 1;132(1):6–13. doi: 10.1016/0003-2697(83)90418-9. [DOI] [PubMed] [Google Scholar]
  20. Gazdar A. F., Carney D. N., Nau M. M., Minna J. D. Characterization of variant subclasses of cell lines derived from small cell lung cancer having distinctive biochemical, morphological, and growth properties. Cancer Res. 1985 Jun;45(6):2924–2930. [PubMed] [Google Scholar]
  21. Goodwin G., Shaper J. H., Abeloff M. D., Mendelsohn G., Baylin S. B. Analysis of cell surface proteins delineates a differentiation pathway linking endocrine and nonendocrine human lung cancers. Proc Natl Acad Sci U S A. 1983 Jun;80(12):3807–3811. doi: 10.1073/pnas.80.12.3807. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Haeder M., Rotsch M., Bepler G., Hennig C., Havemann K., Heimann B., Moelling K. Epidermal growth factor receptor expression in human lung cancer cell lines. Cancer Res. 1988 Mar 1;48(5):1132–1136. [PubMed] [Google Scholar]
  23. Hanauske A. R., Arteaga C. L., Clark G. M., Buchok J., Marshall M., Hazarika P., Pardue R. L., Von Hoff D. D. Determination of transforming growth factor activity in effusions from cancer patients. Cancer. 1988 May 1;61(9):1832–1837. doi: 10.1002/1097-0142(19880501)61:9<1832::aid-cncr2820610919>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
  24. Hwang D. L., Tay Y. C., Lin S. S., Lev-Ran A. Expression of epidermal growth factor receptors in human lung tumors. Cancer. 1986 Nov 15;58(10):2260–2263. doi: 10.1002/1097-0142(19861115)58:10<2260::aid-cncr2820581017>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
  25. Imanishi K., Yamaguchi K., Kuranami M., Kyo E., Hozumi T., Abe K. Inhibition of growth of human lung adenocarcinoma cell lines by anti-transforming growth factor-alpha monoclonal antibody. J Natl Cancer Inst. 1989 Feb 1;81(3):220–223. doi: 10.1093/jnci/81.3.220. [DOI] [PubMed] [Google Scholar]
  26. Johnson B. E., Battey J., Linnoila I., Becker K. L., Makuch R. W., Snider R. H., Carney D. N., Minna J. D. Changes in the phenotype of human small cell lung cancer cell lines after transfection and expression of the c-myc proto-oncogene. J Clin Invest. 1986 Aug;78(2):525–532. doi: 10.1172/JCI112604. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Johnson B. E., Makuch R. W., Simmons A. D., Gazdar A. F., Burch D., Cashell A. W. myc family DNA amplification in small cell lung cancer patients' tumors and corresponding cell lines. Cancer Res. 1988 Sep 15;48(18):5163–5166. [PubMed] [Google Scholar]
  28. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  29. Luk G. D., Goodwin G., Gazdar A. F., Baylin S. B. Growth-inhibitory effects of DL-alpha-difluoromethylornithine in the spectrum of human lung carcinoma cells in culture. Cancer Res. 1982 Aug;42(8):3070–3073. [PubMed] [Google Scholar]
  30. Mabry M., Nakagawa T., Nelkin B. D., McDowell E., Gesell M., Eggleston J. C., Casero R. A., Jr, Baylin S. B. v-Ha-ras oncogene insertion: a model for tumor progression of human small cell lung cancer. Proc Natl Acad Sci U S A. 1988 Sep;85(17):6523–6527. doi: 10.1073/pnas.85.17.6523. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Marquardt H., Hunkapiller M. W., Hood L. E., Todaro G. J. Rat transforming growth factor type 1: structure and relation to epidermal growth factor. Science. 1984 Mar 9;223(4640):1079–1082. doi: 10.1126/science.6320373. [DOI] [PubMed] [Google Scholar]
  32. May W. S., Ihle J. N. Affinity isolation of the interleukin-3 surface receptor. Biochem Biophys Res Commun. 1986 Mar 28;135(3):870–879. doi: 10.1016/0006-291x(86)91009-0. [DOI] [PubMed] [Google Scholar]
  33. McDowell E. M., Barrett L. A., Glavin F., Harris C. C., Trump B. F. The respiratory epithelium. I. Human bronchus. J Natl Cancer Inst. 1978 Aug;61(2):539–549. [PubMed] [Google Scholar]
  34. McDowell E. M., McLaughlin J. S., Merenyl D. K., Kieffer R. F., Harris C. C., Trump B. F. The respiratory epithelium. V. Histogenesis of lung carcinomas in the human. J Natl Cancer Inst. 1978 Aug;61(2):587–606. [PubMed] [Google Scholar]
  35. Nakagawa T., Mabry M., de Bustros A., Ihle J. N., Nelkin B. D., Baylin S. B. Introduction of v-Ha-ras oncogene induces differentiation of cultured human medullary thyroid carcinoma cells. Proc Natl Acad Sci U S A. 1987 Aug;84(16):5923–5927. doi: 10.1073/pnas.84.16.5923. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Nau M. M., Brooks B. J., Battey J., Sausville E., Gazdar A. F., Kirsch I. R., McBride O. W., Bertness V., Hollis G. F., Minna J. D. L-myc, a new myc-related gene amplified and expressed in human small cell lung cancer. Nature. 1985 Nov 7;318(6041):69–73. doi: 10.1038/318069a0. [DOI] [PubMed] [Google Scholar]
  37. Nau M. M., Brooks B. J., Jr, Carney D. N., Gazdar A. F., Battey J. F., Sausville E. A., Minna J. D. Human small-cell lung cancers show amplification and expression of the N-myc gene. Proc Natl Acad Sci U S A. 1986 Feb;83(4):1092–1096. doi: 10.1073/pnas.83.4.1092. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Rein A., Schultz A. M., Bader J. P., Bassin R. H. Inhibitors of glycosylation reverse retroviral interference. Virology. 1982 May;119(1):185–192. doi: 10.1016/0042-6822(82)90075-7. [DOI] [PubMed] [Google Scholar]
  39. Rodenhuis S., van de Wetering M. L., Mooi W. J., Evers S. G., van Zandwijk N., Bos J. L. Mutational activation of the K-ras oncogene. A possible pathogenetic factor in adenocarcinoma of the lung. N Engl J Med. 1987 Oct 8;317(15):929–935. doi: 10.1056/NEJM198710083171504. [DOI] [PubMed] [Google Scholar]
  40. Rosenthal A., Lindquist P. B., Bringman T. S., Goeddel D. V., Derynck R. Expression in rat fibroblasts of a human transforming growth factor-alpha cDNA results in transformation. Cell. 1986 Jul 18;46(2):301–309. doi: 10.1016/0092-8674(86)90747-6. [DOI] [PubMed] [Google Scholar]
  41. Sherwin S. A., Minna J. D., Gazdar A. F., Todaro G. J. Expression of epidermal and nerve growth factor receptors and soft agar growth factor production by human lung cancer cells. Cancer Res. 1981 Sep;41(9 Pt 1):3538–3542. [PubMed] [Google Scholar]
  42. Söderdahl G., Betsholtz C., Johansson A., Nilsson K., Bergh J. Differential expression of platelet-derived growth factor and transforming growth factor genes in small- and non-small-cell human lung carcinoma lines. Int J Cancer. 1988 Apr 15;41(4):636–641. doi: 10.1002/ijc.2910410426. [DOI] [PubMed] [Google Scholar]
  43. Veale D., Ashcroft T., Marsh C., Gibson G. J., Harris A. L. Epidermal growth factor receptors in non-small cell lung cancer. Br J Cancer. 1987 May;55(5):513–516. doi: 10.1038/bjc.1987.104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Wong A. J., Ruppert J. M., Eggleston J., Hamilton S. R., Baylin S. B., Vogelstein B. Gene amplification of c-myc and N-myc in small cell carcinoma of the lung. Science. 1986 Jul 25;233(4762):461–464. doi: 10.1126/science.3014659. [DOI] [PubMed] [Google Scholar]
  45. Xu Y. H., Ishii S., Clark A. J., Sullivan M., Wilson R. K., Ma D. P., Roe B. A., Merlino G. T., Pastan I. Human epidermal growth factor receptor cDNA is homologous to a variety of RNAs overproduced in A431 carcinoma cells. 1984 Jun 28-Jul 4Nature. 309(5971):806–810. doi: 10.1038/309806a0. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES